In a further sign that marijuana has attained legitimacy on Wall Street, Merrill Lynch has initiated coverage on the sector in recent months – and analysts at the firm are particularly optimistic about the prospects of five cannabis companies, whose stocks they rate as Buy. For these five marijuana stocks – including what could be “an off-the-radar play for investors looking for a marijuana play with lower name recognition” – CLICK HERE.
“Making money on marijuana (cannabis with high content of intoxicating THC) and hemp (cannabis that contains low content of THC) will be extremely difficult — except perhaps in one specific area,” advises the author of today’s article, who outlines where he believes the real money in marijuana won’t be made (growers and pharmaceutical companies, to be exact) and that “one specific area” where he believes it will be made. For more, CLICK HERE.
While everything appears to be falling into place for the North American marijuana industry to be an unprecedented growth opportunity, today’s article notes that, when it comes to individual cannabis companies, “Over the past seven months, three marijuana stocks have gone from having the full support of their shareholders to having partially or completely destroyed that faith in management.” For these three pot stocks that have gone from popping with promise to problem-plagued – including the firm the author singles out as “the train wreck of all train wrecks” – CLICK HERE.
With the enormous growth potential associated with recreational marijuana, why might investors in the cannabis space be better off focusing on medical marijuana stocks than recreational marijuana stocks? Today’s article outlines several reasons why “Even though the recreational market is projected to tower over medical cannabis…investors would be smart to hone in on medical marijuana-focused stocks” – and highlights two such cannabis stocks to consider. For more, CLICK HERE.
As marijuana stocks’ impressive run so far this year generates increasing investor interest in the sector, the author of today’s article warns of a danger associated with buying and selling pot stocks, a danger “with which even experienced investors aren’t entirely familiar” and which “can eat into your profits and even turn gains into losses”. That danger? Illiquidity risk. How can you manage illiquidity risk if you want to trade a pot stock not on a major exchange? CLICK HERE.
Facing declining sales in their own industries, and with the global legal cannabis market predicted to be worth $146.4 billion by 2025, tobacco and alcohol companies have been considering – and in some cases making – moves into the cannabis space. Today’s article previews that, this year, “Not only will we see big players entering the sector but there will also be a series of consolidations by large cannabis firms seeking to compete with new entrants” – and highlights one company in the fast-growing CBD sub-sector that may be a particularly tempting acquisition target after the passing of the Farm Bill. For more, CLICK HERE.
“Some will make millions in marijuana stocks, but many more will lose their shirts,” states the author of today’s article, which focuses on the recent run-up in marijuana stocks and how those already invested in marijuana stocks (and those thinking about becoming invested in marijuana stocks) may want to approach it. What does the author identify as the real reason behind the run-up, what do money flows from the “smart money” indicate, and what might various types of pot stock investors – and prospective pot stock investors – want to do now? CLICK HERE.
When 2019 comes to a close, what will have been the biggest developments that impacted marijuana stocks – and which pot stocks will have benefitted the most from those developments? In today’s article, the author provides his answers to those questions – identifying what he believes will be the three critical developments for marijuana stocks to watch this year and the specific stocks that are positioned to be the most likely winners from those developments. For more, CLICK HERE.
With growing social acceptance of marijuana use, and the economic boon legalization has been to states such as Colorado, the author of today’s article believes that “the federal government may just have to reconsider its stance on cannabis” – and proceeds to highlight four marijuana penny stocks that could reap the rewards of such a change in position. For more on these four stocks – including “one of the few names among marijuana penny stocks that’s completely devoted to medicinal marijuana” – CLICK HERE.
Cryptocurrencies and marijuana stocks have more that connects them than the fact that both had impressive showings in 2017. The author of today’s article notes that “what most investors may not realize is that cryptocurrencies and the cannabis industry may soon be tied at the hip. Cryptocurrencies are helping to shape a cannabis industry that’s facing multiple hurdles, especially in the United States where pot is still illegal at the federal level.” The author proceeds to detail “three unique ways cryptocurrencies are attempting to solve major issues for the marijuana industry” – and why this connection is important to investors. CLICK HERE.